Cargando…
Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer
INTRODUCTION: The overall survival rate is good for lymph-node-negative breast cancer patients, but they still suffer from serious over- and some undertreatments. Prognostic and predictive gene signatures for node-negative breast cancer have a high number of genes related to proliferation. The progn...
Autores principales: | Jonsdottir, Kristin, Assmus, Jörg, Slewa, Aida, Gudlaugsson, Einar, Skaland, Ivar, Baak, Jan P. A., Janssen, Emiel A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944091/ https://www.ncbi.nlm.nih.gov/pubmed/24599057 http://dx.doi.org/10.1371/journal.pone.0090642 |
Ejemplares similares
-
Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers
por: Jonsdottir, Kristin, et al.
Publicado: (2012) -
The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
por: Skaland, Ivar, et al.
Publicado: (2009) -
LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009) -
Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019) -
MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
por: Egeland, Nina Gran, et al.
Publicado: (2020)